Merck Releases Pricing Data Days Before Meeting with President

Merck & Co. released their drug pricing information late last week. The data includes drug pricing increases and basic breakdowns of drug costs over the years. Also included in the information was the average discounted rate at which Merck & Co. drugs are sold...

Mylan Facing New Epipen Investigation from FTC

Just one year after Mylan’s pricing controversy, the company is yet again the subject of federal investigation. The Federal Trade Commission has issued a request for information about whether Epipen’s many patent changes effectively shielded it from generic...

Biotech Executives Speak Out About Travel Ban

Over the weekend, President Donald Trump’s executive order restricting travel from specific countries went into effect, leaving many Biotech executives wondering about the free travel of their employees. Xencor CEO, Bassil Dahiyat commented, “We are one of many...